Scientist - High Throughput Screening (m/f/d)

Client Scientific
Location Kraków, Poland
Region Krakow, Poland
Offer description

Selvita is a global integrated service provider with laboratories in Poland (Krakow, Poznan, and Wroclaw), Croatia (Zagreb), and offices in Cambridge, UK, as well as the Greater Boston Area and San Francisco Bay Area in the US. Our company is dedicated to delivering comprehensive solutions that support our international clients in drug discovery and drug development.

As one of the largest preclinical contract research organizations in Europe, Selvita is driven by a clear mission: to bridge the gap between early drug discovery and the clinical stage of drug development.

At Selvita, we value partnership, excellence, passion, commitment, and integrity. We build strong, collaborative relationships with our clients and commit to the highest standards of quality. We fuel our pursuit of innovative solutions with enthusiasm, advance drug development with focused dedication, and ensure honesty and transparency in all our work.

We are seeking a motivated Scientist II to join our High-Throughput Screening team. The successful candidate will be responsible for performing routine biochemical and cell-based screening assays in a fast-paced, automation-driven CRO environment. This is a hands-on laboratory role supporting multiple drug discovery projects.

Join us at Selvita, where these values guide our mission to advance drug discovery to the clinical stage of drug development.

Key Responsibilities
  • Execute routine biochemical and cell-based screening in 384- and 1536-well formats
  • Prepare reagents, plates, controls and other assay components required for HTS campaigns.
  • Convert assays into HTS format, including miniaturization to 384-well and 1536-well format.
  • Perform plate QC checks, monitor assay performance, and ensure compliance with HTS quality criteria (Z’, %CV, S/B, drift).
  • Contribute to assay design and implementation of the key in vitro pharmacology experiments for low-throughput compound profiling (efficacy, selectivity, mechanism of action).
  • Perform HT screens and hit identification.
  • Perform statistical analysis, reporting, and critical data evaluation to support internal drug discovery projects.
  • Maintain high standards of documentation in the electronic lab notebook.
  • Ensure all tasks and responsibilities are performed according to industry-leading scientific and ethical standards and accurately documented in the lab electronic notebook (ELN) system.
  • Good knowledge of flow cytometry will be an advantage.
Your Background
  • MSc in pharmacology, molecular biology, biotechnology or related discipline with minimum of 2 years’ experience in a biotech/pharma setting or Ph.D. in relevant biological sciences.
  • Good knowledge of in vitro pharmacology concepts, with a strong focus on at least one of the following areas: intracellular signaling, cancer metabolism, immunology, or CNS.
  • Experience working with cell lines and cell-based assays in microplate format.
  • Basic understanding of assay performance metrics and data analysis.
  • Strong problem-solving skills, attention to detail, and the ability to follow established protocols.
  • Ability to work efficiently in a team-oriented, dynamic environment.
  • Strong scientific presentation and interpersonal communication skills.
  • Good communication skills and fluency in English.
Your Benefits Package
  • Opportunity to work within an established, fully automated HTS platform.
  • Hands-on experience with state-of-the-art assay technologies and screening equipment.
  • Professional development in an expanding drug discovery organization.
  • Supportive and collaborative team environment.
  • Additional benefits: a prepaid lunch card, private medical care, subsidized sports card, and office fruit provision.
  • Internal Development initiatives, including soft & leadership skills training programs.
  • Recognition Program.
  • Employee Referral Program.
  • Support & incentive bonus for completing Ph.D.
  • Various sports and engagement initiatives.

Last modified Wednesday, February 25, 2026